Carbone, Michele http://orcid.org/0000-0001-8928-8474
Minaai, Michael
Takinishi, Yasutaka
Pagano, Ian
Yang, Haining
Funding for this research was provided by:
Honeywell
Germaine Hope Brennan Foundation
The Maurice and Joanna Sullivan Family Foundation
National Institute of Environmental Health Sciences (1R01ES030948-01)
National Cancer Institute (1R01CA237235-01A1, 1R01CA198138)
U.S. Department of Defense (W81XWH-16-1-0440)
Riviera United-4-a Cure
Melohn Family Endowment
Weinman Foundation
Article History
Received: 5 October 2023
Accepted: 7 October 2023
First Online: 25 October 2023
Declarations
:
: Not applicable.
: Not applicable.
: M.C. has a patent issued for “Methods for Diagnosing a Predisposition to Develop Cancer”. M.C. and H.Y. have patents related to HMGB1 as Biomarker for Asbestos Exposure and Mesothelioma Early Detection, as well as Targeting HMGB1 for Mesothelioma Therapeutic Strategy. M.C. is a board-certified pathologist who provides consultation for pleural pathology, including medical-legal.